Sign In
Free Newsletter
Teva reaches $85M settlement with Oklahoma in opioid lawsuit
NJBIZ STAFF//May 28, 2019
Teva Pharmaceuticals has agreed to pay Oklahoma $85 million to settle a lawsuit brought by the state’s attorney general over the company’s involvement in fueling the opioid epidemic.
The settlement was announced on Sunday by Oklahoma Attorney General Mike Hunter, ahead of a much-anticipated trial on Tuesday against the country’s largest drug manufacturer, New Brunswick-based Johnson & Johnson.
Teva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation’s opioid addiction crisis.
According to Teva’s announcement, the settlement “does not establish any wrongdoing on the part of the company; Teva has not contributed to the abuse of opioids in Oklahoma in any way.” Teva also stated that it “recognizes the devastating impact to communities across the U.S. as a result of illegal drug use and the misuse and abuse of opioids that are available legally by prescription.”
Teva has its U.S. headquarters in Parsippany.
